For the year ending 2025-12-31, BOLT made $7,695K in revenue. -$33,494K in net income. Net profit margin of -435.27%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Collaboration revenue | 7,695 | 7,690 | ||
| Research and development | 28,533 | 57,469 | ||
| General and administrative | 13,795 | 18,457 | ||
| Impairment charges | - | 1,469 | ||
| Restructuring charges | 1,480 | 3,343 | ||
| Total operating expense | 43,808 | 80,738 | ||
| Loss from operations | -36,113 | -73,048 | ||
| Interest income, net | 2,496 | 5,255 | ||
| Other income, net | 241 | 4,675 | ||
| Total other income, net | 2,737 | 9,930 | ||
| Net loss | -33,376 | -63,118 | ||
| Net unrealized (loss) gain on marketable securities | -118 | 60 | ||
| Comprehensive loss | -33,494 | -63,058 | ||
| Basic EPS | -17.85 | -1.65 | ||
| Diluted EPS | -17.85 | -1.65 | ||
| Basic Average Shares | 1,869,924 | 38,183,931 | ||
| Diluted Average Shares | 1,869,924 | 38,183,931 | ||
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)